100 Most Influential People in Healthcare - 2019

Azar has been outspoken on policy issues like soaring drug costs and the need for increased price transparency among providers. In July at the Better Medicare Alliance’s policy summit Azar said that Medicare Advantage could see pay boosts as the Trump’s Administration tackles maternal mortality rates, social determinants of health and rural healthcare access. In November, Azar said the agency was working on an aggressive approach to tying payment for physician-administered drugs in Medicare to foreign drug prices.